Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE
Subjects: FISIOLOGIA, INSUFICIÊNCIA CARDÍACA
ABNT
FERREIRA, Julio Cesar Batista e BRUM, Patricia Chakur e MOCHLY-ROSEN,. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, v. 51, n. 4, p. 479-484, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2010.10.020. Acesso em: 26 set. 2024.APA
Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen,. (2011). βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51( 4), 479-484. doi:10.1016/j.yjmcc.2010.10.020NLM
Ferreira JCB, Brum PC, Mochly-Rosen. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51( 4): 479-484.[citado 2024 set. 26 ] Available from: https://doi.org/10.1016/j.yjmcc.2010.10.020Vancouver
Ferreira JCB, Brum PC, Mochly-Rosen. βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51( 4): 479-484.[citado 2024 set. 26 ] Available from: https://doi.org/10.1016/j.yjmcc.2010.10.020